BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kiezun J, Godlewski J, Krazinski BE, Kozielec Z, Kmiec Z. Galanin Receptors (GalR1, GalR2, and GalR3) Expression in Colorectal Cancer Tissue and Correlations to the Overall Survival and Poor Prognosis of CRC Patients. Int J Mol Sci 2022;23:3735. [PMID: 35409094 DOI: 10.3390/ijms23073735] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Ortega JT, Parmar T, Jastrzebska B. Galanin receptor 3 - A new pharmacological target in retina degeneration. Pharmacol Res 2023;188:106675. [PMID: 36693600 DOI: 10.1016/j.phrs.2023.106675] [Reference Citation Analysis]
2 Kiezun J, Kiezun M, Krazinski BE, Paukszto L, Koprowicz-Wielguszewska A, Kmiec Z, Godlewski J. Galanin Receptors (GALR1, GALR2, and GALR3) Immunoexpression in Enteric Plexuses of Colorectal Cancer Patients: Correlation with the Clinico-Pathological Parameters. Biomolecules 2022;12. [PMID: 36551197 DOI: 10.3390/biom12121769] [Reference Citation Analysis]
3 Srivastava A, Rikhari D, Pradhan B, Bharadwaj KK, Gaballo A, Quarta A, Jena M, Srivastava S, Ragusa A. An Insight into Neuropeptides Inhibitors in the Biology of Colorectal Cancer: Opportunity and Translational Perspectives. Applied Sciences 2022;12:8990. [DOI: 10.3390/app12188990] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
4 Sánchez ML, Coveñas R. The Galaninergic System: A Target for Cancer Treatment. Cancers 2022;14:3755. [DOI: 10.3390/cancers14153755] [Cited by in F6Publishing: 1] [Reference Citation Analysis]